x

iAcquire Phoenix Raises Money for Lymphoma Research

We’re devoted to making systems work, online and in our communities. We’re committed to finding charitable organizations who are doing great work, and lending a hand however we can -- whether through outreach efforts, charitable giving, or volunteerism. From our beginnings in 2009, the foundation of our company remains unchanged: a commitment to clients, employees, and our community.

Our Phoenix office had the opportunity to take part in the 2013 Arizona Lymphomathon. iAcquire’s David Haraldsen, who is the son of a Lymphoma survivor, recounts the event below.

Lymphoma is the most common form of blood cancer that unfortunately all-too-often gets overlooked. An estimated 65,000 new patients are diagnosed with non-Hodgkin lymphoma in the United States each year. As with many types of cancer, most survivors of this disease live with the daunting reality that it can, and most likely will resurface again.

Team Peter

The Lymphoma Research Foundation is a national non-profit organization. Its mission is two-fold; to eradicate lymphoma, and to provide support for all those affected by the disease. They have a scientific advisory board made up of 40 top medical professionals who help to allocate funds for research and make recommendations on clinical trials in search of a cure. LRF also helps patients by providing a number of resources, including disease-specific publications and educational workshops presented at no cost to patients and caregivers.

This year was the 9th annual Arizona Lymphomathon, held each year the Phoenix Zoo. The 2013 race saw an estimated 2,000 participants who together raised almost $125,000 in donations. iAcquire employees joined forces with the 90 members of Team PETER in raising over $11,000 for lymphoma research. Participating iAcquire employees came together to contribute $320 toward the cause, and those who took part in the 5K walk at the Zoo all had a great time and look forward to next year’s event.

Want to get involved?

Check out the team page and join us next year as we continue to search for a cure.